Women’s health

CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda

Modest increase in rate of cardiovascular disease progression during perimenopause for women living with HIV

Implications of restrictions on reproductive rights for HIV care in the USA and beyond

Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192

CROI 2022: Higher maternal mortality and adverse birth outcomes among women with COVID-19 in Botswana

Obesity linked to dolutegravir, especially with TAF, could increase risk of adverse pregnancy outcomes

Long-acting cabotegravir and rilpivirine: similar results in women and men 

Drug-drug interactions between efavirenz and levonorgestrel influenced by genetic variants 

Antiretroviral pharmacokinetics in pregnancy: update from IMPAACT P1026s

Importance of including menopause and bone health in management of HIV positive women

Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Efavirenz and rifampicin together reduce levels of injectable contraception

High rate of unintended pregnancy among HIV positive African women on ART

WHO recommends dolutegravir widely but women’s access will depend on contraception provision (2018)

Dolutegravir: need to consider all pros and cons before switching in pregnancy

Almost 1 in 8 people with symptoms turned away from sexual health clinics in SE London: 40% are under 25 and 6% under 18 years old

Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated

Screening HIV positive pregnant women for TB in South Africa increased detection by 10-fold

Experts disagree with controversial BMJ support for older HIV drugs in pregnancy

Dolutegravir is superior to boosted atazanavir in women in the ARIA study

Doravirine can be co-administered with oral contraceptives

Reducing efavirenz dose is unlikely to overcome interaction with levonorgestrel

Doravirine and cabotegravir do not affect the pharmacokinetics of oral contraceptives

Low prolactin and high 20alpha-HSD might contribute to ART-associated progesterone deficits in pregnancy

Adolescents at increased risk of vertical transmission and poor pregnancy outcome in South Africa

Gender difference in virological response to ART

Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART

Gender differences in use of cardiovascular disease-related interventions: D:A:D study

Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents

Women, HIV research and antiretrovirals

Improved virological outcomes for women starting efavirenz-based first-line regimens in South Africa

High rates of pregnancy in HIV positive women in Zambia and South Africa

Contraceptive choices among a Canadian cohort of HIV positive women

Bone disease and older HIV positive women

Lower immune response to the qHPV vaccine in HIV positive girls

Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness

Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load

Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA

Lopinavir/ritonavir in pregnancy: results from a systematic review

Possible mechanisms for adverse pregnancy outcomes in HIV positive women

Hormonal contraception and the risk of HIV acquisition

Intimate partner violence towards HIV positive women in the UK

Hormonal contraception: HIV transmission and progression rates

Darunavir use during pregnancy

The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women

Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort

Atazanavir in pregnancy: 155 cases in London clinics

Lopinavir/ritonavir: women versus men

Quality of life in the GRACE study

Antiretroviral pharmacokinetics in women with undetectable viral load

No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy

The impact of antiretroviral treatment on fertility intentions in South Africa

Cotrimoxazole with or without sulfadoxine-pyrimethamine reduces malaria in pregnant women

Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg

HPV-based screen-and-treat is effective for cervical cancer prevention in HIV-positive women

Genital tract viral load in women with below detectable plasma viral load

Lime juice is not a microbicide: do not try at home

Maternal TB, HIV and pregnancy

Central fat accumulation remains a significant problem in patients starting HAART after 2005 with higher incidence in women compared to men

No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

Gender-based differences in patients receiving antiretroviral therapy

No effect of hormonal contraception on HIV disease progression in large multi-country cohort

HAART suppresses genital tract HIV shedding in HIV/HSV co-infected women

Efavirenz significantly reduces levels of some oral contraceptives

The unmet need for contraception services for women receiving ART

Post navigation